ARETE DISCOVERIES

Arête Discoveries is a biotech research discovery firm formed to develop treatments to stop the progression of autoimmune diseases. Our research focuses on the innate immune system and the epigenetic impact on tissues throughout the human body. The first target of Arête's research is amyotrophic lateral sclerosis (ALS). The one commonality in all neurodegenerative disease is inflammation. Our candidates, ART201a and ART201b (ART201), work in multiple mechanisms of action to reduce, even eliminate, harmful inflammation, prevent pathogenesis and stimulate stromal precursor cells, providing tissue repair and amelioration of disease. We will use nanotechnology to deliver ART201 directly to diseased tissue, greatly reducing the possibility of adverse reactions, side effects or toxicity... Arête Discoveries has taken an entirely novel approach to both understanding autoimmune disease, and uncovering heretofore unknown biological interactions. We believe we have found the trigger, the..

Also known as: Arete Discoveries, Inc.

Primary location: Weston United States